Inovio Pharmaceuticals, Inc. (INO) financial statements (2022 and earlier)

Company profile

Business Address 6769 MESA RIDGE RD.
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:4014129081127105163
Cash and cash equivalents712512224241958
Short-term investments330161675810486105
Other undisclosed cash, cash equivalents, and short-term investments(0)(0)(0)(0)   
Receivables819246177
Prepaid expense115     
Other undisclosed current assets283633432
Total current assets:4484719488138125172
Noncurrent Assets
Operating lease, right-of-use asset121314
Property, plant and equipment171113161897
Long-term investments and receivables 0 991615
Long-term investments 0 991615
Intangible assets, net (including goodwill)13141415171814
Goodwill11111111111110
Intangible assets, net (excluding goodwill)3345684
Other noncurrent assets12633321
Other undisclosed noncurrent assets4460245
Total noncurrent assets:47695043494942
TOTAL ASSETS:496540144131187174214
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:48211823232013
Accrued liabilities   6963
Employee-related liabilities161399874
Other undisclosed accounts payable and accrued liabilities32898776
Deferred revenue000
Debt  2    
Deferred rent credit   1
Due to related parties1111110
Deferred revenue and credits21514
Contract with customer, liability0
Other undisclosed current liabilities18201110984
Total current liabilities:66423235354431
Noncurrent Liabilities
Long-term debt and lease obligation151820    
Operating lease, liability151820
Liabilities, other than long-term debt0099966
Deferred revenue and credits966
Deferred revenue000
Contract with customer, liability0
Deferred rent credit   9
Deferred tax liabilities, net  00
Deferred income tax liabilities000
Other liabilities0000   
Derivative instruments and hedges, liabilities  9    
Other undisclosed noncurrent liabilities1519770001
Total noncurrent liabilities:31371079976
Total liabilities:967913944455038
Stockholders' equity
Stockholders' equity attributable to parent400461387142123176
Common stock0000000
Additional paid in capital1,6101,367743708666557534
Accumulated other comprehensive income (loss)(0)(0)0(1)(0)13
Accumulated deficit(1,210)(906)(740)(620)(523)(435)(361)
Stockholders' equity attributable to noncontrolling interest  20000
Total stockholders' equity:400461587142123176
TOTAL LIABILITIES AND EQUITY:496540144131187174214

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues37430423541
Revenue, net423541
Net investment income333    
Gross profit:37430423541
Operating expenses(303)(131)(115)(125)(126)(112)(75)
Other undisclosed operating loss(2)      
Operating loss:(301)(124)(111)(94)(84)(76)(34)
Nonoperating income030    
Investment income, nonoperating 4     
Other nonoperating income (expense)0(1)0    
Interest and debt expense(2)(9)(8)    
Loss from continuing operations before equity method investments, income taxes:(303)(129)(119)(94)(84)(76)(34)
Other undisclosed income (loss) from continuing operations before income taxes(0)(34)(2)(1)(5)23
Loss from continuing operations before income taxes:(303)(163)(121)(95)(88)(74)(31)
Income tax expense (benefit)  0(2)  2
Loss before gain (loss) on sale of properties:(303)(163)(121)(97)(88)(74)(29)
Other undisclosed net loss(0)(5)     
Net loss:(304)(167)(121)(97)(88)(74)(29)
Net income (loss) attributable to noncontrolling interest 11   (0)
Net loss attributable to parent:(304)(166)(119)(97)(88)(74)(29)
Other undisclosed net loss available to common stockholders, basic    (1) (1)
Net loss available to common stockholders, diluted:(304)(166)(119)(97)(89)(74)(30)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(304)(167)(121)(97)(88)(74)(29)
Other comprehensive income  0    
Other undisclosed comprehensive income (loss)(0)(1)1(0)(1)(1)3
Comprehensive loss:(304)(168)(120)(97)(90)(75)(26)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest 11   (0)
Other undisclosed comprehensive income, net of tax, attributable to parent      0
Comprehensive loss, net of tax, attributable to parent:(304)(167)(118)(97)(90)(75)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: